Massachusetts Financial Services CO Moderna, Inc. Transaction History

Massachusetts Financial Services CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$135.66 - $197.02 $1.03 Million - $1.5 Million	7,627 Added 170.44%	12,102 $1.86 Million
Q4 2022 Feb 13, 2023	SELL	$118.38 - $210.04 $4.54 Million - $8.06 Million	-38,352 Reduced 89.55%	4,475 $803,000
Q3 2022 Nov 09, 2022	BUY	$118.07 - $194.18 $1.27 Million - $2.1 Million	10,793 Added 33.69%	42,827 $5.06 Million
Q2 2022 Aug 09, 2022	SELL	$117.13 - $176.59 $2.03 Million - $3.07 Million	-17,370 Reduced 35.16%	32,034 $4.58 Million
Q1 2022 May 11, 2022	BUY	$126.46 - $235.05 $2.85 Million - $5.3 Million	22,543 Added 83.92%	49,404 $8.51 Million
Q4 2021 Feb 10, 2022	BUY	$225.82 - $368.51 $1.98 Million - $3.24 Million	8,781 Added 48.57%	26,861 $6.82 Million
Q3 2021 Nov 10, 2021	BUY	$221.9 - $484.47 $1.18 Million - $2.58 Million	5,323 Added 41.73%	18,080 $6.96 Million
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $433,249 - $783,658	3,335 Added 35.4%	12,757 $3 Million
Q1 2021 May 13, 2021	BUY	$109.18 - $185.98 $1.03 Million - $1.75 Million	9,422 New	9,422 $1.23 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.